Many compounding pharmacies are no longer allowed to make cheaper versions of semaglutide and other GLP-1 drugs. A doctor explains options for patients.

Receiving a generic version of Ozempic or Wegovy from a compounding pharmacy is normally both easier to access and cheaper.

Compounding pharmacies will no longer be allowed to create semaglutide injections, a generic and cheaper version of Ozempic and Wegovy. This comes after a judge rejected a bid by these pharmacies to ...

Big compounders will have until May 22 to stop producing and dispensing compounded semaglutide, while smaller, state-run ...

With GLP-1 shortage officially over, patients who relied on compounded copies have only bad options to choose from ...

The ruling means that small-scale compounders must immediately stop making their versions of Novo’s Ozempic and Wegovy, while ...

Discover How Success by Sesame’s Affordable, Telehealth-Driven Weight Loss Program Combines Compounded Semaglutide, ...

The astronomical rise in popularity of GLP-1RAs in recent years has led to a shortage, prompting users to turn to compounders ...

For example, many patients have relied on compounding pharmacies for access to wildly popular diabetes and weight loss drugs, ...

As the FDA cracks down on compounded GLP-1 drugs like semaglutide and tirzepatide, the market for GLP-1 supplements is taking ...

Eli Lilly sued four telehealth firms, but it is adopting a new legal strategy in its fight against compounded GLP-1s.

The Food and Drug Administration had determined there is no longer a shortage of drugs like Ozempic and Wegovy, therefore it had set ending dates for the use of the compounded prescriptions made of ...